Sex-Associated Plasma Cell-Free DNA Methylation Patterns in Indonesian Lung Cancer: An Exploratory Study
This exploratory study of treatment-induction Indonesian women with lung cancer found no statistically significant sex-associated differences in plasma cfDNA concentration, global methylation index, or most locus-specific methylation patterns, with a single unadjusted finding of higher MGMT methylation in men requiring further validation in larger cohorts.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Lung cancer has long been viewed as a disease of heavy smokers, a pattern that historically skewed toward men. Yet in recent decades, the landscape has shifted. Lung cancer is increasingly diagnosed in women, many of whom have never smoked a cigarette in their lives. In Indonesia, this trend is particularly pronounced, where the disease claims more lives than any other cancer, yet the biological reasons behind why it strikes women differently remain largely a mystery. To understand these differences, scientists are looking beyond the tumor itself and into the bloodstream. Inside the blood of anyone with cancer, tiny fragments of DNA float freely, shed by dying cells. These fragments, known as cell-free DNA, carry chemical tags called methylation. Think of these tags as sticky notes attached to a document; they do not change the words on the page, but they tell the cell how to read the instructions, turning genes on or off. Because these tags change in specific ways when cancer develops, scientists hope to read them to detect the disease, understand its behavior, and perhaps see if it acts differently in men and women.
A team of researchers in Jakarta recently set out to explore these chemical tags specifically in Indonesian women with lung cancer. They recruited thirteen women who had just been diagnosed and had not yet received any treatment. These women were gathered from a national respiratory hospital, representing a group where active smoking was absent, but exposure to second-hand smoke was common. The researchers drew blood from each woman, isolated the floating DNA fragments, and used a specialized process to read the methylation tags on specific genes known to be involved in cancer. They also measured the total amount of DNA in the blood and calculated a summary score, called a global methylation index, which acts like a broad average of how many chemical tags were present across the entire set of genes they examined. To provide context, they compared the women's results with data from thirteen men in the same study and with reference data from healthy lung tissue.
The study painted a clear picture of the women involved. Most were in their sixties, and nearly all had a history of exposure to smoke from others, even though none were active smokers themselves. The vast majority had a specific type of lung cancer called adenocarcinoma, and most were already at an advanced stage of the disease. When the researchers looked at the blood, they found that the amount of floating DNA varied widely from person to person, ranging from about 8 to 12 nanograms per milliliter. However, this amount did not seem to depend on how large the tumor was, how far the cancer had spread, or whether the patient had a specific genetic mutation. Similarly, the broad summary score of methylation tags showed no clear connection to the patient's age, the stage of their cancer, or their history of exposure to smoke. The chemical landscape of the blood seemed to be a complex mix that did not simply rise or fall with the severity of the disease in this small group.
When the scientists zoomed in to look at individual genes, they found one intriguing difference between the men and the women. A gene known as MGMT, which helps repair damaged DNA, showed a higher level of chemical tagging in the men than in the women. However, this difference was small and did not hold up when the researchers applied strict statistical rules to account for the fact that they were looking at multiple genes at once. For the other genes they examined, including those involved in controlling cell growth and preventing cancer, there was no significant difference between the sexes. The researchers also noted that the chemical tags in the women's blood were generally higher than those found in healthy lung tissue, which is expected in cancer, but the specific patterns did not offer a clear, standalone signal to identify the disease or predict its course.
The researchers concluded that while the study provided a detailed snapshot of lung cancer in Indonesian women, the tools they used—the total amount of DNA in the blood and the broad average of chemical tags—were not yet ready to serve as reliable, stand-alone tests for this specific group. The single gene difference they spotted between men and women is a hint that requires further investigation in much larger groups of people. For now, the study confirms that lung cancer in Indonesian women often appears without active smoking and frequently involves specific genetic changes, but it also shows that the chemical signals in the blood are too varied to be used as a simple diagnostic tool on their own. The work serves as a necessary first step, gathering local data to help future scientists build better methods that can one day distinguish the unique biology of lung cancer in women from that in men.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.